ZOIA Healthcare and Meta Healthcare Announce Exclusive U.S. Partnership to Expand Access to Ready-to-Use Nutrition Solutions for Individuals with Maple Syrup Urine Disease
ZOIA Healthcare has partnered with Meta Healthcare to distribute ready-to-use liquid valine and isoleucine solutions in the U.S. for patients with Maple Syrup Urine Disease. The partnership includes comprehensive patient support services to improve access to these specialized medical foods.
Why it matters
This partnership addresses a critical gap in care for patients with rare metabolic disorders by streamlining the distribution and reimbursement process.
VANCOUVER, Wash., June 25, 2026 (GLOBE NEWSWIRE) -- ZOIA Healthcare, Inc. (ZOIA), a leading provider of medical foods and low-protein nutrition solutions for individuals with inherited metabolic disorders, today announced an exclusive partnership with Meta Healthcare Ltd. to introduce its ready-to-use (RTU) liquid valine and isoleucine oral solutions to the U.S. market and expand access for individuals living with Maple Syrup Urine Disease (MSUD).
The article is a factual business announcement regarding a healthcare partnership.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in